Evaluation of Extended Intravenous of Beta-lactams in the Treatment of Serious Gram-negative Infections in Critically Ill Patients

NCT01600768 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Gram-Negative Bacterial Infections

Interventions

DRUG: Beta-Lactams
DRUG: Beta-Lactams

Sponsor

National Taiwan University Hospital